CLOSE
Loading...
12° Nicosia,
22 April, 2025
 
Home  /  News

January approval for AstraZeneca vaccine by EMA unlikely

It is unlikely that the EMA will approve the AstraZeneca coronavirus vaccine by January, as minimal information on the vaccine has been submitted

Source: Reuters

The European Medicines Authority (EMA) will most likely not be able to approve the Covid-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog's Deputy Executive Director Noel Wathion said.

"They have not even filed an application with us yet", Wathion said in an interview with Belgian newspaper Het Nieuwsblad published on Tuesday.

European regulators have only received some information about the vaccine, Wathion said.

"Not even enough to warrant a conditional marketing licence", he said. "We need additional data about the quality of the vaccine. And after that, the company has to formally apply."

This made it "improbable" that an approval could already be granted next month, Wathion said.

The EMA could not be reached for comment.

AstraZeneca told Reuters last week that its Covid-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.

It has submitted a full data package about its vaccine to the British medicines regulator, British health minister Matt Hancock said.

TAGS
vaccine  |  coronavirus  |  health  |  AstraZeneca  |  EMA

News: Latest Articles

Photos of Finikoudes Beach by Phillipos Christou and a village in snowy Troodos

From summer hotspot to all-year hub

Pancyprian Hotel Association President urges innovation and perseverance to keep Cyprus competitive in a fast-changing tourism ...
Newsroom
 |  NEWS
Akamas for sale?

Akamas for sale?

Rampant illegal development, political blind spots, and a culture of impunity are threatening Cyprus’s most protected natural ...
Newsroom
 |  NEWS
X